Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04AAW
|
|||
| Former ID |
DAP001083
|
|||
| Drug Name |
Cidofovir
|
|||
| Synonyms |
CDV; Cidofovirum; Forvade; HPMPC; Vistide; Cidofovir anhydrous; GS 0504; GS 504; GS504; Cidofovir (Vistide); Cidofovir (anhydrous); GS-0504; GS-504; Vistide (TN); Vistide, Cidofovir; [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid; (2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine; (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine; (S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid; (S)-HPMPC; (s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid; ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid; 1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine; 1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cytomegalovirus infection [ICD-11: 1D82] | Approved | [1] | |
| Therapeutic Class |
Anti-HIV Agents
|
|||
| Company |
Pfizer Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H14N3O6P
|
|||
| Canonical SMILES |
C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O
|
|||
| InChI |
1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1
|
|||
| InChIKey |
VWFCHDSQECPREK-LURJTMIESA-N
|
|||
| CAS Number |
CAS 113852-37-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
596838, 7978941, 8186963, 12014233, 14848679, 14972788, 43117987, 46506054, 50007425, 57314045, 76063703, 85240541, 91146456, 92718864, 93578310, 103208535, 104253188, 104321212, 109692921, 117588193, 124757308, 124896571, 125164112, 126628422, 126655266, 126664430, 126669928, 129535965, 134222323, 134338340, 135018697, 136920390, 136946528, 136949097, 137005936, 142388054, 144115830, 144206546, 151994247, 160963716, 162011514, 164778525, 164807829, 174007460, 175268249, 179149625, 196106556, 196403991, 210275592, 210281251
|
|||
| ChEBI ID |
CHEBI:3696
|
|||
| ADReCS Drug ID | BADD_D00463 ; BADD_D00464 | |||
| SuperDrug ATC ID |
J05AB12
|
|||
| SuperDrug CAS ID |
cas=113852372
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Herpes simplex virus DNA polymerase UL30 (HSV UL30) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging antiviral drugs. Expert Opin Emerg Drugs. 2008 Sep;13(3):393-416. | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.